‘Blood clots are a major cause of maternal morbidity and mortality. We developed THROMBOCALC, a new electronic risk assessment tool, to enable us to rapidly carry out a risk assessment on women in very busy maternity hospitals and delivery suites.'
'The tool stratifies patients into low, moderate and high risk categories and provides recommendations on treatment, medication doses and duration. The project achievements were only made possible by the dedication and hard work of our midwives in the Delivery Suite and Theatre who have completed in excess of 6500 risk assessments to date’, said Prof. Brian Cleary on behalf of the THROMBOCALC team: Dr. Sharon Cooley, Dr. Fionnuala Ni Ainle, Mary Deering, Ajita Raman, Dr. Jennifer Donnelly and Alan Holland.
The team began work on THROMBOCALC as part of the Rotunda/RCSI Leadership Development Programme in 2014.
Graham Love, Chief Executive at the Health Research Board added,
‘It wasn’t just the innovation that struck us about this application it was the ambition. The team identified a critical health-care need, and worked with colleagues on the ground to address that need. Having validated the product and its usability with frontline staff, the team have gone on to develop an intranet-based version of this tool and plan for the integration of “Thrombocalc” into the electronic health record that will be used for in excess of 75,000 deliveries nationally. It has great potential to make a real impact and save lives.
Prof Cleary is a graduate of one of the HRB’s postgraduate training programmes, and it is obvious from this work and award, that our investments are paying dividends and patients will benefit as a result. I would like to extend my sincere congratulations to everyone involved with the project.’